Prosztatarák: vizsgálatok itt: Kína
252 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
- Where
- Beijing, Hangzhou, Wuhan, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 430 worldwide
- Run by
- Pfizer
See details and how to joinNCT04557449 · EU 2024-512120-11-00 - No phaseTaking peoplePET/CT Imaging Study With Simultaneous Dual-nuclide Imaging Technique
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 35
- Run by
- Xijing Hospital
See details and how to joinNCT06914427 - No phaseTaking people68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer
- Where
- Xiamen
- Életkor
- 18 év and over
- People
- 25
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07885423 - 3. fázisTaking peopleStudy of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
- Where
- Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Huaian, Jiaxing, Kunming, Nanchang, Nanchong, Nanjing, Ningbo, Shanghai, Suining, Tianjin, Ürümqi, Wenzhou, Wuhan, Wuxi, Xiamen, Xi'an, Yantai
- Életkor
- 18 év and over
- People
- 1310 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06136624 · EU 2023-504899-25-00 - 2. fázisTaking peopleA Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Before Surgery for Men Who Have High-risk Localized Prostate Cancer.
- Where
- Beijing, Chengdu, Dongyang, Fuzhou, Guangzhou, Harbin, Hefei, Jinan, Jinhua, Kunming, Lanzhou, Nanchang, Nanjing, Shanghai, Shenyang, Shijiazhuang, Tianjin, Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 250
- Run by
- Bayer
See details and how to joinNCT07450599 - 1. fázisTaking peopleA Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- Where
- Beijing, Guangzhou, Shanghai
- Életkor
- 18 év and over
- People
- 460 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06465069 · EU 2024-512927-36-00 - 1. fázisTaking peopleA Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Where
- Beijing, Tianjin
- Életkor
- 18 év and over
- People
- 421 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07114601 · EU 2025-522367-15-00 - 1. fázisTaking peopleA Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Where
- Chongqing, Wenzhou, Xi'an
- Életkor
- 18 év and over
- People
- 355 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06095089 · EU 2023-504063-17-00 - No phaseTaking peopleEvaluation of Perilesional Biopsy in Diagnosis of Prostate Cancer
- Where
- Beijing
- Életkor
- 45 év to 85 év
- People
- 640
- Run by
- Peking University First Hospital
See details and how to joinNCT06482645 - 3. fázisTaking peopleA Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Beijing, Changchun, Chengdu, Chongqing, Guangzhou, Nanjing, Nanning, Nantong, Ningbo, Shanghai, Tianjin, Wenzhou, Wuhan, Xi'an
- Életkor
- 18 év and over
- People
- 1203 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07164443 · EU 2025-520927-26-00 - 3. fázisTaking peopleA Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Where
- Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanjing, Shanghai, Tianjin, Wuhan, Xi'an
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07225946 · EU 2025-522713-29-00 - 2. fázisTaking peopleA Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer
- Where
- Guangzhou, Wenzhou
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07832292 - No phaseTaking peopleThe Application of Somatosensory Interactive Pelvic Floor Muscle Training for Stress Urinary Incontinence in Men Underwent Radical Prostatectomy
- Where
- Shanghai
- Életkor
- 18 év to 85 év
- People
- 100 worldwide
- Run by
- The University of Hong Kong
See details and how to joinNCT06740071 - 1/2. fázisNot yet taking people in KínaPSMA-specific CAR-T Cell Therapy
- Where
- Shenzhen
- Életkor
- 1 év to 75 év
- People
- 100
- Run by
- Shenzhen Geno-Immune Medical Institute
See details and how to joinNCT04429451 - 3. fázisTaking peopleA Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
- Where
- Beijing, Changsha, Chengdu, Fuzhou, Guangzhou, Guilin, Hangzhou, Hohhot, Huai'an, Jiaxing, Jinan, Nanjing, Nantong, Ningbo, Qingdao, Shanghai, Shantou, Shenyang, Suzhou, Tianjin, Weifang, Wenzhou, Wuhan, Wuhu, Xi'an, Xi’an, Xinxiang, Yantai, Zhengzhou
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- Pfizer
See details and how to joinNCT06629779 · EU 2024-511652-40-00 - 3. fázisTaking peopleA Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Where
- Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Hangzhou, Jiaxing, Jinan, Nanjing, Nanning, Ningbo, Shanghai, Taiyuan, Ürümqi, Wenzhou, Wuhan, Xi'an, Xuzhou, Zhengzhou, Zhuhai
- Életkor
- 18 év and over
- People
- 1440 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06925737 · EU 2024-517423-40-00 - 2. fázisNot yet taking people in KínaDeutenzalutamide and Hormone Therapy Before and After Surgery With Docetaxel Before Surgery for High-Risk Localized or Locally Advanced Prostate Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 80 év
- People
- 37
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07907653 - 2. fázisTaking peopleDapagliflozin Combined With Next-generation Hormonal Agent (NHA) Versus Single NHA in Participants With Metastatic Castrate-resistant Prostate Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 68
- Run by
- Yung NA
See details and how to joinNCT07310433 - 1. fázisTaking peopleAXT-1003 Combination With Enzalutamide in Participants With mCRPC
- Where
- Changsha, Guangzhou, Ningbo, Shanghai
- Életkor
- 18 év and over
- People
- 105
- Run by
- Axter Therapeutics (Beijing) Co., Ltd
See details and how to joinNCT07897071 - 2. fázisTaking peopleA Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Where
- Chengdu, Guangzhou
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06172478 · EU 2023-507641-29-00 - 1. fázisTaking peopleA Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
- Where
- Guangzhou, Shanghai, Wenzhou
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT07244341 · EU 2025-522512-16-00 - 1. fázisTaking peopleA Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer
- Where
- Beijing
- Életkor
- 18 év to 85 év
- People
- 12
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07339267 - 1/2. fázisTaking peopleStudy of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Where
- Changsha, Chengdu, Wuhan
- Életkor
- 18 év to 130 év
- People
- 283 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07181161 · EU 2024-520026-11-00 - 2. fázisTaking peopleStudy of PF-07248144 in Advanced or Metastatic Solid Tumors
- Where
- Beijing, Changchun, Guangzhou, Xi’an
- Életkor
- 18 év and over
- People
- 320 worldwide
- Run by
- Pfizer
See details and how to joinNCT04606446 - 1/2. fázisTaking peopleA Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
- Where
- Baoding, Beijing, Changchun, Changsha, Chengdu, Chongqing, Fuzhou, Ganzhou, Guangzhou, Hangzhou, Harbin, Hefei, Jinan, Linyi, Luoyang, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Taizhou, Tianjin, Wuhan, Xi’an, Xinxiang, Zhengzhou
- Életkor
- 18 év and over
- People
- 862 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05914116